Indications and Process Analysis for IVF in Thailand with Polycystic Ovaries

Document Meta Information

1. Direct Answer: Is IVF in Thailand Suitable for Polycystic Ovaries?

For patients with Polycystic Ovary Syndrome (PCOS) considering IVF in Thailand, the core conclusion is: Provided metabolic status is optimized, IVF in Thailand can offer an effective path to pregnancy for PCOS patients, but it is not suitable for all PCOS patients, nor is it a solution to all problems just by going there.

IVF technology addresses fertilization and embryo formation, not the direct treatment of PCOS itself. The core value of IVF for PCOS patients lies in three aspects: ① Obtaining a sufficient number of mature eggs through a suitable ovulation induction protocol; ② Reducing the risk of miscarriage due to fluctuating egg quality through embryo selection (including PGT); ③ Avoiding the risk of Ovarian Hyperstimulation Syndrome (OHSS) associated with repeated ovulation induction.

When is it Suitable?

• BMI < 28, stably maintained through lifestyle intervention or medication (e.g., Metformin).
• Fasting blood glucose < 6.1 mmol/L, or OGTT 2-hour blood glucose < 7.8 mmol/L, with no uncontrolled impaired glucose tolerance.
• No persistent clinical manifestations of hyperandrogenism (e.g., active acne, progressive hirsutism), or controlled after medical intervention.
• Previous ovulation induction resulted in immature follicle development or high OHSS risk.
• Coexisting tubal factor, male factor, or other indications requiring IVF.

When is it Not Suitable?

• BMI > 32 without any metabolic intervention.
• Fasting blood glucose > 7.0 mmol/L or HbA1c > 7.0%, indicating uncontrolled diabetes.
• Untreated thyroid dysfunction (e.g., uncontrolled hypothyroidism or hyperthyroidism).
• Severe insulin resistance (fasting insulin > 20 μU/ml) without medication.
• Presence of uncontrolled metabolic syndrome (concurrent abdominal obesity, hyperglycemia, dyslipidemia, hypertension).

2. Standard IVF Process in Thailand for PCOS Patients

The entire cycle is divided into four stages, of which the metabolic intervention stage is most easily overlooked but has the greatest impact on the outcome.

Stage 1: Pre-cycle Assessment and Metabolic Intervention (Completed in Home Country, Recommended 3 Months in Advance)

• Comprehensive Check-up: AMH, Sex Hormone Profile (including FSH, LH), OGTT (3-hour, 5 blood draws) + Insulin Release Test, Full Lipid Profile, Liver and Kidney Function, Thyroid Function, Male Semen Analysis.
• Metabolic Intervention: Low-GI diet + Regular exercise (at least 150 minutes of moderate-intensity aerobic activity per week), Metformin if necessary (usually requires 8–12 weeks of continuous use to improve egg quality).
• Target Values: BMI < 28, Fasting blood glucose < 6.1 mmol/L, OGTT 2h blood glucose < 7.8 mmol/L.

Stage 2: Ovulation Induction in Thailand (Duration in Thailand: Approximately 14–18 Days)

• Menstrual cycle day 2–3: Baseline ultrasound + Hormone testing, start ovulation induction (PPOS protocol or modified long protocol are more common for PCOS patients, with lower OHSS risk).
• During ovulation induction: Follicle development + Hormone levels (E2, LH, P) monitored every 2–3 days.
• Trigger: Use GnRH agonist trigger (instead of hCG) to reduce OHSS risk.
• Egg Retrieval: Transvaginal ultrasound-guided egg retrieval, procedure time approximately 15–20 minutes.

Stage 3: Laboratory Stage (Duration in Thailand: Approximately 5–7 Days)

• IVF or ICSI fertilization (decision based on male semen analysis).
• Blastocyst culture (5–6 days), assessment of developmental potential and morphological grade.
• PGT (if indicated for chromosomal abnormality screening) — Thailand allows embryo chromosomal screening, but a clear distinction between medical indications and non-medical selection must be made.
• Whole Embryo Freezing: Recommended for PCOS patients to optimize the metabolic environment before scheduled transfer.

Stage 4: Frozen Embryo Transfer (Second Visit to Thailand, Approximately 12–14 Days)

• Endometrial Preparation: Down-regulation + HRT protocol (Hormone Replacement Cycle), or Natural Cycle (suitable for those with regular ovulation).
• Endometrial Transformation: Transfer blastocyst on day 5–6 after progesterone transformation.
• Luteal Phase Support after Transfer: Use progesterone gel or injections, continued until pregnancy test 12–14 days after transfer.

3. Reproductive Specialist Perspective: Metabolic Assessment is More Critical Than Ovulation Induction Protocol

In my years of practice, the most common problem before IVF for PCOS patients is: starting the cycle prematurely with an incomplete metabolic assessment. Many people only check their fasting blood glucose in their home country, and if it's normal, they assume their metabolism is fine. Only after arriving in Thailand and completing an OGTT do they discover impaired glucose tolerance or significant insulin resistance.

From a clinical decision-making logic, when a doctor faces a PCOS patient, they first answer three questions:

1. Is the metabolic status acceptable to enter the cycle? — Mainly assessed by BMI, blood glucose, insulin, lipids, and blood pressure.
2. How to balance the number of eggs retrieved with OHSS risk in the ovulation induction protocol? — Patients with AMH > 5 ng/ml or AFC > 20 are at high risk for OHSS and should choose a mild protocol or PPOS protocol.
3. Whole embryo freezing or fresh embryo transfer? — For PCOS patients, especially those with high peak E2 levels after ovulation induction or poor endometrial morphology, the live birth rate is usually better with whole embryo freezing followed by scheduled transfer.

Furthermore, male evaluation cannot be omitted. The proportion of PCOS patients with concurrent male factor infertility is not lower than the general population. Semen analysis should be completed before traveling to Thailand to decide if ICSI is needed and if a sperm freeze backup is necessary.

4. Key Differences in PCOS Patient Management Between China and Thailand

The main differences in IVF management for PCOS patients between Thailand and China lie in ovulation induction strategies, transfer habits, and medication choices. The following is an objective comparison:

Differences themselves do not represent superiority or inferiority; the key is whether the patient's individual condition matches the protocol. For example, PCOS patients with very high AMH (> 10 ng/ml) might be more suitable for IVM or mild stimulation protocols offered by some centers in Thailand to reduce OHSS risk.

5. Strategy Differences Among Reproductive Centers in Thailand

Management of PCOS patients is not standardized across reproductive centers in Thailand. The following four points require special attention:

• IVM Technology Application: Some centers routinely perform In Vitro Maturation (IVM) of immature eggs, suitable for very high OHSS risk patients, but blastocyst formation rates are usually lower than conventional IVF, requiring a risk-benefit assessment.
• Ovulation Induction Protocol Preference: Some centers prefer mild protocols (targeting 10–15 eggs), while others use conventional stimulation protocols (yielding 20–30 eggs). Protocol selection should be based on the patient's AMH, AFC, and previous response to ovulation induction.
• Laboratory Blastocyst Culture Capability: Egg quality in PCOS patients is easily affected by the metabolic environment. The lab's ability to consistently culture high-quality blastocysts directly determines the chance of transfer. It is advisable to inquire about the center's blastocyst formation rate and freeze-thaw survival rate data from the last 1–2 years.
• Metabolic Management Requirements: A few centers require patients to complete metabolic optimization and medication monitoring locally before starting ovulation induction; most accept patients who have completed optimization in their home country before traveling to Thailand. This needs to be confirmed with the medical team in advance.

6. Four Most Easily Overlooked Details

• ① OGTT must be the 3-hour, 5 blood draw version. Checking only fasting blood glucose misses impaired glucose tolerance in about 40% of cases, and impaired glucose tolerance is an independent factor affecting egg quality and increasing miscarriage rates.
• ② Metformin needs to be taken for 8–12 weeks in advance. This drug requires a sufficient time window to improve egg quality and lower fasting insulin levels; taking it for just 3–5 days is virtually useless.
• ③ Endometrial receptivity is affected by insulin resistance. Even if the embryo is chromosomally normal and morphologically well-graded, insulin resistance can still lead to implantation failure. The endometrial preparation protocol after down-regulation needs individualization; some patients may require an extended down-regulation period.
• ④ Male semen analysis should be completed before traveling to Thailand. The rate of semen abnormalities in partners of PCOS patients is not low. If severe oligoasthenospermia is present, preparations for ICSI or sperm freezing need to be made in advance to avoid passive waiting in Thailand.

7. Four Common Decision-Making Misconceptions

Misconception 1: Many follicles = High success rate

This is the most common cognitive bias. A high number of follicles does not mean good egg quality. The proportion of immature eggs (GV stage, MI stage) is usually higher in PCOS patients compared to age-matched non-PCOS women, and the MII egg rate (mature egg rate) tends to be lower. When more than 20 eggs are retrieved, the proportion of immature eggs can reach 30%–40%.

Misconception 2: Blindly choosing a mild stimulation protocol

Some PCOS patients respond poorly to mild stimulation, and retrieving fewer eggs can actually increase the cycle cancellation rate. Protocol selection should be based on AMH, AFC, and previous response to ovulation induction, rather than a one-size-fits-all belief that "mild stimulation is safer."

Misconception 3: Ignoring the male factor

The cause of infertility in PCOS patients may include a male factor. Semen analysis should be completed before planning to start the cycle. Some couples only discover in Thailand that ICSI or even donor sperm is needed, leading to last-minute protocol changes or extended stays.

Misconception 4: Whole embryo freezing is always better than fresh embryo transfer

Whole embryo freezing does reduce OHSS risk, but it is not suitable for all PCOS patients. The pregnancy rate after frozen embryo transfer can be lower than fresh transfer for some patients, especially when embryo quality is average and post-thaw survival is uncertain. The decision should be based on a comprehensive assessment of embryo grade, endometrial status, and metabolic indicators.

8. Frequently Asked Questions